Time-dependent changes in proinflammatory and neurotrophic responses of microglia and astrocytes in a rat model of osmotic demyelination syndrome

GLIA

Volumn 59, Issue 3, 2011, Pages 452-462

  Iwama, Shintaro ^a   Sugimura, Yoshihisa ^a   Suzuki, Haruyuki ^a   Suzuki, Hiromi ^b   Murase, Takashi ^c   Ozaki, Nobuaki ^a   Nagasaki, Hiroshi ^a   Arima, Hiroshi ^a   Murata, Yoshiharu ^a   Sawada, Makoto ^b   Oiso, Yutaka ^a  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b NAGOYA UNIVERSITY   (Japan)

^c JAPANESE RED CROSS NAGOYA FIRST HOSPITAL   (Japan)

Author keywords

Hyponatremia; Infliximab; Matrix metalloproteinase; Neurotrophic factor; Proinflammatory cytokine

Indexed keywords

CYTOKINE; GELATINASE A; GELATINASE B; GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR; INFLIXIMAB; INTERLEUKIN 1BETA; INTERLEUKIN 6; LEUKEMIA INHIBITORY FACTOR; MACROPHAGE ELASTASE; MESSENGER RNA; NERVE GROWTH FACTOR; NITRIC OXIDE SYNTHASE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASTROCYTE; CELL FUNCTION; CONTROLLED STUDY; DEMYELINATING DISEASE; HYPONATREMIA; MALE; MICROGLIA; NONHUMAN; OSMOTIC DEMYELINATION SYNDROME; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RAT;

ANIMALS; ASTROCYTES; DEMYELINATING DISEASES; DISEASE MODELS, ANIMAL; HYPONATREMIA; MALE; MICROGLIA; OSMOSIS; RATS; RATS, SPRAGUE-DAWLEY; SYNDROME; TIME FACTORS; WATER-ELECTROLYTE IMBALANCE;

EID: 78751689395     PISSN: 08941491     EISSN: 10981136     Source Type: Journal    
DOI: 10.1002/glia.21114     Document Type: Article

References (58)

1. Adler S, Verbalis JG, Williams D. 1995. Effect of rapid correction of hyponatremia on the blood-brain barrier of rats. Brain Res 679: 135-143.
2. Akiyama H, Tooyama I, Kondo H, Ikeda K, Kimura H, McGeer EG, McGeer PL. 1994. Early response of brain resident microglia to kainic acid-induced hippocampal lesions. Brain Res 635: 257-268.
3. Aloisi F. 2001. Immune function of microglia. Glia 36: 165-179.
4. Andrews T, Zhang P, Bhat NR. 1998. TNFalpha potentiates IFNgamma-induced cell death in oligodendrocyte progenitors. J Neurosci Res 54: 574-583.
5. Arnett HA, Mason J, Marino M, Suzuki K, Matsushima GK, Ting JP. 2001. TNF alpha promotes proliferation of oligodendrocyte progenitors and remyelination. Nat Neurosci 4: 1116-1122.
6. Arredondo LR, Deng C, Ratts RB, Lovett-Racke AE, Holtzman DM, Racke MK. 2001. Role of nerve growth factor in experimental autoimmune encephalomyelitis. Eur J Immunol 31: 625-633.
7. Baker EA, Tian Y, Adler S, Verbalis JG. 2000. Blood-brain barrier disruption and complement activation in the brain following rapid correction of chronic hyponatremia. Exp Neurol 165: 221-230.
8. Bannerman P, Hahn A, Soulika A, Gallo V, Pleasure D. 2007. Astrogliosis in EAE spinal cord: Derivation from radial glia, and relationships to oligodendroglia. Glia 55: 57-64.
9. Bitsch A, Kuhlmann T, Da Costa C, Bunkowski S, Polak T, Bruck W. 2000. Tumour necrosis factor alpha mRNA expression in early multiple sclerosis lesions: Correlation with demyelinating activity and oligodendrocyte pathology. Glia 29: 366-375.
10. Brogi A, Strazza M, Melli M, Costantino-Ceccarini E. 1997. Induction of intracellular ceramide by interleukin-1 beta in oligodendrocytes. J Cell Biochem 66: 532-541.
11. Cammer W. 2000. Effects of TNFalpha on immature and mature oligodendrocytes and their progenitors in vitro. Brain Res 864: 213-219.
12. Crocker SJ, Frausto RF, Whitton JL, Milner R. 2008. A novel method to establish microglia-free astrocyte cultures: Comparison of matrix metalloproteinase expression profiles in pure cultures of astrocytes and microglia. Glia 56: 1187-1198.
13. De Groot CJ, Ruuls SR, Theeuwes JW, Dijkstra CD, Van der Valk P. 1997. Immunocytochemical characterization of the expression of inducible and constitutive isoforms of nitric oxide synthase in demyelinating multiple sclerosis lesions. J Neuropathol Exp Neurol 56: 10-20.
14. DeLuca GC, Nagy Z, Esiri MM, Davey P. 2002. Evidence for a role for apoptosis in central pontine myelinolysis. Acta Neuropathol 103: 590-598.
15. Fromont A, De Seze J, Fleury MC, Maillefert JF, Moreau T. 2009. Inflammatory demyelinating events following treatment with anti-tumor necrosis factor. Cytokine 45: 55-57.
16. Gankam Kengne F, Soupart A, Pochet R, Brion JP, Decaux G. 2009. Re-induction of hyponatremia after rapid overcorrection of hyponatremia reduces mortality in rats. Kidney Int 76: 614-621.
17. Hanisch UK, Kettenmann H. 2007. Microglia: Active sensor and versatile effector cells in the normal and pathologic brain. Nat Neurosci 10: 1387-1394.
18. Hendriks JJ, Slaets H, Carmans S, de Vries HE, Dijkstra CD, Stinissen P, Hellings N. 2008. Leukemia inhibitory factor modulates production of inflammatory mediators and myelin phagocytosis by macrophages. J Neuroimmunol 204: 52-57.
19. Heppner FL, Greter M, Marino D, Falsig J, Raivich G, Hovelmeyer N, Waisman A, Rulicke T, Prinz M, Priller J, Becher B, Aguzzi A. 2005. Experimental autoimmune encephalomyelitis repressed by microglial paralysis. Nat Med 11: 146-152.
20. Ishibashi T, Dakin KA, Stevens B, Lee PR, Kozlov SV, Stewart CL, Fields RD. 2006. Astrocytes promote myelination in response to electrical impulses. Neuron 49: 823-832.
21. Kleinschmidt-DeMasters BK, Norenberg MD. 1981. Rapid correction of hyponatremia causes demyelination: Relation to central pontine myelinolysis. Science 211: 1068-1070.
22. Kotter MR, Li WW, Zhao C, Franklin RJ. 2006. Myelin impairs CNS remyelination by inhibiting oligodendrocyte precursor cell differentiation. J Neurosci 26: 328-332.
23. Lalancette-Hebert M, Gowing G, Simard A, Weng YC, Kriz J. 2007. Selective ablation of proliferating microglial cells exacerbates ischemic injury in the brain. J Neurosci 27: 2596-2605.
24. Li J, Baud O, Vartanian T, Volpe JJ, Rosenberg PA. 2005. Peroxynitrite generated by inducible nitric oxide synthase and NADPH oxidase mediates microglial toxicity to oligodendrocytes. Proc Natl Acad Sci USA 102: 9936-9941.
25. Lien YH, Shapiro JI, Chan L. 1991. Study of brain electrolytes and organic osmolytes during correction of chronic hyponatremia. Implications for the pathogenesis of central pontine myelinolysis. J Clin Invest 88: 303-309.
26. Liu T, Clark RK, McDonnell PC, Young PR, White RF, Barone FC, Feuerstein GZ. 1994. Tumor necrosis factor-alpha expression in ischemic neurons. Stroke 25: 1481-1488.
27. Louis JC, Magal E, Takayama S, Varon S. 1993. CNTF protection of oligodendrocytes against natural and tumor necrosis factor-induced death. Science 259: 689-692.
28. Mason JL, Suzuki K, Chaplin DD, Matsushima GK. 2001. Interleukin-1beta promotes repair of the CNS. J Neurosci 21: 7046-7052.
29. Murase T, Sugimura Y, Takefuji S, Oiso Y, Murata Y. 2006. Mechanisms and therapy of osmotic demyelination. Am J Med 119 (7, Suppl 1): S69-S73.
30. Nakanishi M, Niidome T, Matsuda S, Akaike A, Kihara T, Sugimoto H. 2007. Microglia-derived interleukin-6 and leukaemia inhibitory factor promote astrocytic differentiation of neural stem/progenitor cells. Eur J Neurosci 25: 649-658.
31. Nicole O, Ali C, Docagne F, Plawinski L, MacKenzie ET, Vivien D, Buisson A. 2001. Neuroprotection mediated by glial cell line-derived neurotrophic factor: Involvement of a reduction of NMDA-induced calcium influx by the mitogen-activated protein kinase pathway. J Neurosci 21: 3024-3033.
32. Nimmerjahn A, Kirchhoff F, Helmchen F. 2005. Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo. Science 308: 1314-1318.
33. Panickar KS, Norenberg MD. 2005. Astrocytes in cerebral ischemic injury: Morphological and general considerations. Glia 50: 287-298.
34. Rapoport SI. 2000. Osmotic opening of the blood-brain barrier: Principles, mechanism, and therapeutic applications. Cell Mol Neurobiol 20: 217-230.
35. Rojiani AM, Prineas JW, Cho ES. 1994. Electrolyte-induced demyelination in rats. I. Role of the blood-brain barrier and edema. Acta Neuropathol 88: 287-292.
36. Selmaj K, Raine CS, Cross AH. 1991. Anti-tumor necrosis factor therapy abrogates autoimmune demyelination. Ann Neurol 30: 694-700.
37. Silberberg DH, Manning MC, Schreiber AD. 1984. Tissue culture demyelination by normal human serum. Ann Neurol 15: 575-580.
38. Silver SM, Schroeder BM, Sterns RH, Rojiani AM. 2006. Myoinositol administration improves survival and reduces myelinolysis after rapid correction of chronic hyponatremia in rats. J Neuropathol Exp Neurol 65: 37-44.
39. Soupart A, Penninckx R, Crenier L, Stenuit A, Perier O, Decaux G. 1994. Prevention of brain demyelination in rats after excessive correction of chronic hyponatremia by serum sodium lowering. Kidney Int 45: 193-200.
40. Soupart A, Silver S, Schrooeder B, Sterns R, Decaux G. 2002. Rapid (24-hour) reaccumulation of brain organic osmolytes (particularly myo-inositol) in azotemic rats after correction of chronic hyponatremia. J Am Soc Nephrol 13: 1433-1441.
41. Soupart A, Stenuit A, Perier O, Decaux G. 1991. Limits of brain tolerance to daily increments in serum sodium in chronically hyponatraemic rats treated with hypertonic saline or urea: Advantages of urea. Clin Sci (Lond) 80: 77-84.
42. South SA, Deibler GE, Tzeng SF, Badache A, Kirchner MG, Muja N, De Vries GH. 2000. Myelin basic protein (MBP) and MBP peptides are mitogens for cultured astrocytes. Glia 29: 81-90.
43. Sterns RH, Baer J, Ebersol S, Thomas D, Lohr JW, Kamm DE. 1993. Organic osmolytes in acute hyponatremia. Am J Physiol 264 (5, Part 2): F833-F836.
44. Sterns RH, Riggs JE, Schochet SSJr. 1986. Osmotic demyelination syndrome following correction of hyponatremia. N Engl J Med 314: 1535-1542.
45. Sterns RH, Thomas DJ, Herndon RM. 1989. Brain dehydration and neurologic deterioration after rapid correction of hyponatremia. Kidney Int 35: 69-75.
46. Strelau J, Unsicker K. 1999. GDNF family members and their receptors: Expression and functions in two oligodendroglial cell lines representing distinct stages of oligodendroglial development. Glia 26: 291-301.
47. Sugimura Y, Murase T, Takefuji S, Hayasaka S, Takagishi Y, Oiso Y, Murata Y. 2005. Protective effect of dexamethasone on osmotic-induced demyelination in rats. Exp Neurol 192: 178-183.
48. Takefuji S, Murase T, Sugimura Y, Takagishi Y, Hayasaka S, Oiso Y, Murata Y. 2007. Role of microglia in the pathogenesis of osmotic-induced demyelination. Exp Neurol 204: 88-94.
49. Targan SR, Hanauer SB, van Deventer SJ, Mayer L, Present DH, Braakman T, DeWoody KL, Schaible TF, Rutgeerts PJ. 1997. A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohn's disease. Crohn's Disease cA2 Study Group. N Engl J Med 337: 1029-1035.
50. van Oosten BW, Barkhof F, Truyen L, Boringa JB, Bertelsmann FW, von Blomberg BM, Woody JN, Hartung HP, Polman CH. 1996. Increased MRI activity and immune activation in two multiple sclerosis patients treated with the monoclonal anti-tumor necrosis factor antibody cA2. Neurology 47: 1531-1534.
51. Vartanian T, Li Y, Zhao M, Stefansson K. 1995. Interferon-gamma-induced oligodendrocyte cell death: Implications for the pathogenesis of multiple sclerosis. Mol Med 1: 732-743.
52. Verbalis JG, Gullans SR. 1991. Hyponatremia causes large sustained reductions in brain content of multiple organic osmolytes in rats. Brain Res 567: 274-282.
53. Verbalis JG, Gullans SR. 1993. Rapid correction of hyponatremia produces differential effects on brain osmolyte and electrolyte reaccumulation in rats. Brain Res 606: 19-27.
54. Videen JS, Michaelis T, Pinto P, Ross BD. 1995. Human cerebral osmolytes during chronic hyponatremia. A proton magnetic resonance spectroscopy study. J Clin Invest 95: 788-793.
55. Vos CM, van Haastert ES, de Groot CJ, van der Valk P, de Vries HE. 2003. Matrix metalloproteinase-12 is expressed in phagocytotic macrophages in active multiple sclerosis lesions. J Neuroimmunol 138: 106-114.
56. Wang Q, Tang XN, Yenari MA. 2007. The inflammatory response in stroke. J Neuroimmunol 184: 53-68.
57. Wren DR, Noble M. 1989. Oligodendrocytes and oligodendrocyte/type-2 astrocyte progenitor cells of adult rats are specifically susceptible to the lytic effects of complement in absence of antibody. Proc Natl Acad Sci USA 86: 9025-9029.
58. Yu AC, Liu RY, Zhang Y, Sun HR, Qin LY, Lau LT, Wu BY, Hui HK, Heung MY, Han JS. 2007. Glial cell line-derived neurotrophic factor protects astrocytes from staurosporine- and ischemia-induced apoptosis. J Neurosci Res 85: 3457-3464.